PlushCare Is the First Virtual Care Company to Offer Free Nationwide Antibody Testing Appointments for In-Network Patients Amid COVID-19

By AIT News Desk On Apr 25, 2020

PlushCare Is Partnering With Quest Diagnostics to Offer Antibody Test to Americans

PlushCare, the leading virtual health platform, announces that they will be the FIRST telehealth platform to offer nationwide access to antibody testing amid COVID-19. The antibody test will determine if a patient has previously been infected with the COVID-19 virus, and can also potentially predict immunity to the virus going forward. PlushCare accepts most major insurance plans and is offering free appointments and COVID-19 antibody testing for their in-network patients.

To get a test, simply book a virtual appointment with a PlushCare doctor via the app and upon receiving a doctor’s order, users will be able to gain access to the antibody test at a local Quest Diagnostics Service Center. For safety concerns, all patients must be symptom-free for a minimum of 10 days to qualify for the test and will have their temperature checked upon arrival. Results can take as little as 24 hours.

Lightning AI Raises $50Million to Simplify and Scale AI Development For Enterprises and Developers

Nov 22, 2024

Teach Mode Is Here: rabbit Gives Consumers Power to Create Custom AI Agents

Nov 22, 2024

Lumina AI Welcomes Jason Sultz to Advisory Board to Strengthen AI and Advanced Compute Expertise

Nov 22, 2024

Prev Next 1 of 40,411

“At PlushCare, we are consistently working to provide our patients with the most up-to date services possible, especially during the COVID-19 pandemic,” said Dr. James Wantuck, Chief Medical Officer and Co-Founder of PlushCare. “We pride ourselves that this new blood test that PlushCare is offering is highly accurate and will be another step forward to fight this virus and reopen the country.”

As news of COVID-19 is rapidly changing on a daily basis, PlushCare is helping to pioneer and push forward antibody testing with the hope of benefiting patients on a national level by helping to determine the presence of IgG antibodies. IgG antibodies in the blood are produced by the body in response to SARS-CoV-2 virus. The importance of these results will help to determine the next stages of the virus for the United States as it relates to state re-openings and when that process should take place.